0001209191-18-048821.txt : 20180829
0001209191-18-048821.hdr.sgml : 20180829
20180829170130
ACCESSION NUMBER: 0001209191-18-048821
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180827
FILED AS OF DATE: 20180829
DATE AS OF CHANGE: 20180829
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAUDLIN TIMOTHY I
CENTRAL INDEX KEY: 0001115047
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
STATE OF INCORPORATION: MN
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38034
FILM NUMBER: 181044874
MAIL ADDRESS:
STREET 1: C/O SUCAMPO PHARMACEUTICALS, INC.
STREET 2: 4520 EAST-WEST HIGHWAY, 3RD FLOOR
CITY: BETHESDA
STATE: MD
ZIP: 20814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alteryx, Inc.
CENTRAL INDEX KEY: 0001689923
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 900673106
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3345 MICHELSON DRIVE
STREET 2: SUITE 400
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: (888) 836-4274
MAIL ADDRESS:
STREET 1: 3345 MICHELSON DRIVE
STREET 2: SUITE 400
CITY: IRVINE
STATE: CA
ZIP: 92612
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-27
0
0001689923
Alteryx, Inc.
AYX
0001115047
MAUDLIN TIMOTHY I
C/O ALTERYX, INC.
3345 MICHELSON DRIVE, SUITE 400
IRVINE
CA
92612
1
0
0
0
Class A Common Stock
2018-08-27
4
C
0
9286
0.00
A
24095
D
Class A Common Stock
2018-08-27
4
S
0
20000
55.67
D
4095
D
Stock Option (Right to Buy)
11.88
2018-08-27
4
M
0
9286
0.00
D
2018-01-05
2025-12-19
Class B Common Stock
9286
123370
D
Class B Common Stock
0.00
2018-08-27
4
M
0
9286
0.00
A
Class A Common Stock
9286
9286
D
Class B Common Stock
0.00
2018-08-27
4
C
0
9286
0.00
D
Class A Common Stock
9286
0
D
Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date.
Includes 4,095 shares subject to an award of restricted stock units which shall fully vest on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) June 13, 2019, in each case, so long as the non-employee director continues to provide services to the Issuer through such date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.50 to $56.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the earliest to occur of the following: (a) the date specified by a vote of the holders of 66 2/3% of the outstanding shares of Class B Common Stock, (b) March 23, 2027, and (c) the date the shares of Class B Common Stock cease to represent at least 10% of all outstanding shares of Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date.
/s/ Christopher M. Lal, by power of attorney
2018-08-29